Insider trade

Officer sold ~$2.37M of LLY shares in the open market

Traded Aug 10, 2026 · Filed Aug 11, 2026

Eli LillyLLY

~$2.37M
Reported value · 2,000 sh @ $1,185.01: 1,525.89
Holds after · shares reported: -6.7%
stock since the trade · S&P 500 -1.2%, $1,231.94 → $1,149.85 on Oct 1

Why it stands out

Eli Lilly's SVP, Finance, & CAO sold $2.37M of Eli Lilly shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 10, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 11, 2026

Officer$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,370,020

Shares × reported transaction price

Timing vs results

5 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $1,231.94 on Aug 10, 2026, within 1% of its 52-week high, after a 2% rise over the previous 30 trading days

52-week range $635.22 (Aug 11, 2025) to $1,235.56 (Jul 7, 2026), 99% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,208.12 on Jun 26, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

FDA decision near the trade

FDA approved Zepbound on Aug 26, 2026, 16 days after this trade.

New use approved (efficacy supplement). Active ingredient: Tirzepatide. From openFDA. Dates only; no link between the two is implied

After it was reported

After	Stock	S&P 500	Difference
7 days	+4.9%	-0.4%	+5.4%
30 days	-8.6%	-1.1%	-7.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0000059478-26-000083
Filed / recorded: Aug 11, 2026, 8:31 PM UTC
Added to OQRO: Oct 2, 2026, 3:52 AM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: ELI LILLY & Co
Issuer CIK: 59478
Ticker: LLY
Reporting person: Donald A Zakrowski
Relationship: Officer
Officer title: SVP, Finance, & CAO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Aug 10, 2026
Transaction code: S
Shares / units: 2,000
Price per share: $1,185.01
Acquired / disposed: Disposed (D)
Shares owned after: 1,525.89
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026.

Around the same time

4w ago

13Shares

Gift or transfer — classified separately from trades.

Why it stands out Official record

4w ago

216Shares

Gift or transfer — classified separately from trades.

Why it stands out Official record

6w ago

Congress trade

$1,001 - $15,000Reported range · official band, not an exact amount

9 different filers disclosed LLY within 90 days. Disclosed 276 days after the transaction; reported as an official range, not an exact amount.

Why it stands out Official record